Skip to main content

Table 5 Multivariate analysis for breast cancer-specific overall survival

From: Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing

Prognostic factor P RR 95% CI
Age n.s. - -
Menopausal status n.s. - -
pT stage n.s. - -
Grade 0.0007 3.89 1.77–8.55
Steroid hormone receptor status n.s. - -
HER2_SCO n.s. - -
HER2_AMP 0.016 3.08 1.24–7.66
HER2_ALG n.s. - -
HER2_COM n.s. - -
  1. CI, confidence interval; n.s., not significant; RR, relative risk.